Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    Bruce Gaynor, MD

    TitleAssistant Professor
    SchoolUCSF Chancellor/EVC/FAS
    DepartmentProctor Foundation
    Address513 Parnassus Ave, Med Sci
    San Francisco CA 94143
    Phone415-502-8843

       Bibliographic 
       Publications
      Publications by year:
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      1. Amza A, Kadri B, Nassirou B, Yu SN, Stoller NE, Bhosai SJ, Zhou Z, McCulloch CE, West SK, Bailey RL, Keenan JD, Lietman TM, Gaynor BD. The Easiest Children to Reach Are Most Likely to Be Infected with Ocular Chlamydia trachomatis in Trachoma Endemic Areas of Niger. PLoS Negl Trop Dis. 2013 Jan; 7(1):e1983.
        View in: PubMed
      2. Amza A, Kadri B, Nassirou B, Stoller NE, Yu SN, Zhou Z, West SK, Mabey DC, Bailey RL, Keenan JD, Porco TC, Lietman TM, Gaynor BD. A cluster-randomized controlled trial evaluating the effects of mass azithromycin treatment on growth and nutrition in Niger. Am J Trop Med Hyg. 2013 Jan; 88(1):138-43.
        View in: PubMed
      3. Cevallos V, Whitcher JP, Melese M, Alemayehu W, Yi E, Chidambaram JD, Lee S, Reddy H, Gaynor BD, Lietman TM, Keenan JD. Association of conjunctival bacterial infection and female sex in cicatricial trachoma. Invest Ophthalmol Vis Sci. 2012 Aug; 53(9):5208-12.
        View in: PubMed
      4. Bhosai SJ, Amza A, Beido N, Bailey RL, Keenan JD, Gaynor BD, Lietman TM. Application of smartphone cameras for detecting clinically active trachoma. Br J Ophthalmol. 2012 Oct; 96(10):1350-1.
        View in: PubMed
      5. Bhosai SJ, Bailey RL, Gaynor BD, Lietman TM. Trachoma: an update on prevention, diagnosis, and treatment. Curr Opin Ophthalmol. 2012 Jul; 23(4):288-95.
        View in: PubMed
      6. Amza A, Kadri B, Nassirou B, Stoller NE, Yu SN, Zhou Z, Chin S, West SK, Bailey RL, Mabey DC, Keenan JD, Porco TC, Lietman TM, Gaynor BD. Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial. PLoS Negl Trop Dis. 2012; 6(4):e1586.
        View in: PubMed
      7. Keenan JD, See CW, Moncada J, Ayele B, Gebre T, Stoller NE, McCulloch CE, Porco TC, Gaynor BD, Emerson PM, Schachter J, Lietman TM. Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions. Invest Ophthalmol Vis Sci. 2012 Jan; 53(1):235-40.
        View in: PubMed
      8. Ayele B, Aemere A, Gebre T, Tadesse Z, Stoller NE, See CW, Yu SN, Gaynor BD, McCulloch CE, Porco TC, Emerson PM, Lietman TM, Keenan JD. Reliability of measurements performed by community-drawn anthropometrists from rural Ethiopia. PLoS One. 2012; 7(1):e30345.
        View in: PubMed
      9. Maher MC, Alemayehu W, Lakew T, Gaynor BD, Haug S, Cevallos V, Keenan JD, Lietman TM, Porco TC. The fitness cost of antibiotic resistance in Streptococcus pneumoniae: insight from the field. PLoS One. 2012; 7(1):e29407.
        View in: PubMed
      10. Gebre T, Ayele B, Zerihun M, Genet A, Stoller NE, Zhou Z, House JI, Yu SN, Ray KJ, Emerson PM, Keenan JD, Porco TC, Lietman TM, Gaynor BD. Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial. Lancet. 2012 Jan 14; 379(9811):143-51.
        View in: PubMed
      11. Ayele B, Gebre T, Moncada J, House JI, Stoller NE, Zhou Z, Porco TC, Gaynor BD, Emerson PM, Schachter J, Keenan JD. Risk factors for ocular chlamydia after three mass azithromycin distributions. PLoS Negl Trop Dis. 2011 Dec; 5(12):e1441.
        View in: PubMed
      12. Oldenburg CE, Acharya NR, Tu EY, Zegans ME, Mannis MJ, Gaynor BD, Whitcher JP, Lietman TM, Keenan JD. Practice patterns and opinions in the treatment of acanthamoeba keratitis. Cornea. 2011 Dec; 30(12):1363-8.
        View in: PubMed
      13. Keenan JD, Moncada J, Gebre T, Ayele B, Chen MC, Yu SN, Emerson PM, Stoller NE, McCulloch CE, Gaynor BD, Schachter J. Chlamydial infection during trachoma monitoring: are the most difficult-to-reach children more likely to be infected? Trop Med Int Health. 2012 Mar; 17(3):392-6.
        View in: PubMed
      14. Keenan JD, Ayele B, Gebre T, Moncada J, Stoller NE, Zhou Z, Porco TC, McCulloch CE, Gaynor BD, Emerson PM, Schachter J, Lietman TM. Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma. Clin Infect Dis. 2012 Jan 15; 54(2):253-6.
        View in: PubMed
      15. Gebre T, Ayele B, Zerihun M, House JI, Stoller NE, Zhou Z, Ray KJ, Gaynor BD, Porco TC, Emerson PM, Lietman TM, Keenan JD. Latrine promotion for trachoma: assessment of mortality from a cluster-randomized trial in Ethiopia. Am J Trop Med Hyg. 2011 Sep; 85(3):518-23.
        View in: PubMed
      16. See CW, Alemayehu W, Melese M, Zhou Z, Porco TC, Shiboski S, Gaynor BD, Eng J, Keenan JD, Lietman TM. How reliable are tests for trachoma?--a latent class approach. Invest Ophthalmol Vis Sci. 2011 Aug; 52(9):6133-7.
        View in: PubMed
      17. Ayele B, Gebre T, House JI, Zhou Z, McCulloch CE, Porco TC, Gaynor BD, Emerson PM, Lietman TM, Keenan JD. Adverse events after mass azithromycin treatments for trachoma in Ethiopia. Am J Trop Med Hyg. 2011 Aug; 85(2):291-4.
        View in: PubMed
      18. Oldenburg CE, Keenan JD, Cevallos V, Chan MF, Acharya NR, Gaynor BD, McLeod SD, Esterberg EJ, Porco TC, Lietman TM. Microbiological cure times in acanthamoeba keratitis. Eye (Lond). 2011 Sep; 25(9):1155-60.
        View in: PubMed
      19. Fintelmann RE, Hoskins EN, Lietman TM, Keenan JD, Gaynor BD, Cevallos V, Acharya NR. Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures. Arch Ophthalmol. 2011 Apr; 129(4):399-402.
        View in: PubMed
      20. Keenan JD, Lakew T, Alemayehu W, Melese M, House JI, Acharya NR, Porco TC, Gaynor BD, Lietman TM. Slow resolution of clinically active trachoma following successful mass antibiotic treatments. Arch Ophthalmol. 2011 Apr; 129(4):512-3.
        View in: PubMed
      21. Keenan JD, Ayele B, Gebre T, Zerihun M, Zhou Z, House JI, Gaynor BD, Porco TC, Emerson PM, Lietman TM. Childhood mortality in a cohort treated with mass azithromycin for trachoma. Clin Infect Dis. 2011 Apr 1; 52(7):883-8.
        View in: PubMed
      22. Skalet AH, Cevallos V, Ayele B, Gebre T, Zhou Z, Jorgensen JH, Zerihun M, Habte D, Assefa Y, Emerson PM, Gaynor BD, Porco TC, Lietman TM, Keenan JD. Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial. PLoS Med. 2010; 7(12):e1000377.
        View in: PubMed
      23. Haug S, Lakew T, Habtemariam G, Alemayehu W, Cevallos V, Zhou Z, House J, Ray K, Porco T, Rutar T, Keenan J, Lietman TM, Gaynor BD. The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma. Clin Infect Dis. 2010 Sep 1; 51(5):571-4.
        View in: PubMed
      24. Shah NA, House J, Lakew T, Alemayehu W, Halfpenny C, Hong KC, Keenan JD, Porco TC, Whitcher JP, Lietman TM, Gaynor BD. Travel and implications for the elimination of trachoma in ethiopia. Ophthalmic Epidemiol. 2010 Mar; 17(2):113-7.
        View in: PubMed
      25. Keenan JD, Lakew T, Alemayehu W, Melese M, Porco TC, Yi E, House JI, Zhou Z, Ray KJ, Acharya NR, Whitcher JP, Gaynor BD, Lietman TM. Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma. Am J Trop Med Hyg. 2010 Mar; 82(3):482-7.
        View in: PubMed
      26. Biebesheimer JB, House J, Hong KC, Lakew T, Alemayehu W, Zhou Z, Moncada J, Rogér A, Keenan J, Gaynor BD, Schachter J, Lietman TM. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions. Ophthalmology. 2009 Nov; 116(11):2047-50.
        View in: PubMed
      27. Porco TC, Gebre T, Ayele B, House J, Keenan J, Zhou Z, Hong KC, Stoller N, Ray KJ, Emerson P, Gaynor BD, Lietman TM. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA. 2009 Sep 2; 302(9):962-8.
        View in: PubMed
      28. Lakew T, Alemayehu W, Melese M, Yi E, House JI, Hong KC, Zhou Z, Ray KJ, Porco TC, Gaynor BD, Lietman TM, Keenan JD. Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution. PLoS Negl Trop Dis. 2009; 3(8):e507.
        View in: PubMed
      29. House JI, Ayele B, Porco TC, Zhou Z, Hong KC, Gebre T, Ray KJ, Keenan JD, Stoller NE, Whitcher JP, Gaynor BD, Emerson PM, Lietman TM. Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial. Lancet. 2009 Mar 28; 373(9669):1111-8.
        View in: PubMed
      30. Lakew T, House J, Hong KC, Yi E, Alemayehu W, Melese M, Zhou Z, Ray K, Chin S, Romero E, Keenan J, Whitcher JP, Gaynor BD, Lietman TM. Reduction and return of infectious trachoma in severely affected communities in Ethiopia. PLoS Negl Trop Dis. 2009; 3(2):e376.
        View in: PubMed
      31. Melese M, Alemayehu W, Lakew T, Yi E, House J, Chidambaram JD, Zhou Z, Cevallos V, Ray K, Hong KC, Porco TC, Phan I, Zaidi A, Gaynor BD, Whitcher JP, Lietman TM. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma. JAMA. 2008 Feb 20; 299(7):778-84.
        View in: PubMed
      32. Gill DA, Lakew T, Alemayehu W, Melese M, Zhou Z, House JI, Hong KC, Ray KJ, Gandhi N, Whitcher JP, Gaynor BD, Lietman TM. Complete elimination is a difficult goal for trachoma programs in severely affected communities. Clin Infect Dis. 2008 Feb 15; 46(4):564-6.
        View in: PubMed
      33. Ray KJ, Porco TC, Hong KC, Lee DC, Alemayehu W, Melese M, Lakew T, Yi E, House J, Chidambaram JD, Whitcher JP, Gaynor BD, Lietman TM. A rationale for continuing mass antibiotic distributions for trachoma. BMC Infect Dis. 2007; 7:91.
        View in: PubMed
      34. Lee S, Alemayehu W, Melese M, Lakew T, Lee D, Yi E, Cevallos V, Donnellan C, Zhou Z, Chidambaram JD, Gaynor BD, Whitcher JP, Lietman TM. Chlamydia on children and flies after mass antibiotic treatment for trachoma. Am J Trop Med Hyg. 2007 Jan; 76(1):129-31.
        View in: PubMed
      35. Gaynor BD. World blindness: the problem with prevalence. Int Ophthalmol Clin. 2007; 47(3):xiii-xv.
        View in: PubMed
      36. House J, Gaynor B, Taylor H, Lietman TM. The real challenge: can we discover why trachoma is disappearing before it's gone? Int Ophthalmol Clin. 2007; 47(3):63-76.
        View in: PubMed
      37. Yang JL, Schachter J, Moncada J, Habte D, Zerihun M, House JI, Zhou Z, Hong KC, Maxey K, Gaynor BD, Lietman TM. Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma. Br J Ophthalmol. 2007 Mar; 91(3):293-5.
        View in: PubMed
      38. Chidambaram JD, Alemayehu W, Melese M, Lakew T, Yi E, House J, Cevallos V, Zhou Z, Maxey K, Lee DC, Shapiro BL, Srinivasan M, Porco T, Whitcher JP, Gaynor BD, Lietman TM. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA. 2006 Mar 8; 295(10):1142-6.
        View in: PubMed
      39. Gaynor BD, Chidambaram JD, Cevallos V, Miao Y, Miller K, Jha HC, Bhatta RC, Chaudhary JS, Osaki Holm S, Whitcher JP, Holbrook KA, Fry AM, Lietman TM. Topical ocular antibiotics induce bacterial resistance at extraocular sites. Br J Ophthalmol. 2005 Sep; 89(9):1097-9.
        View in: PubMed
      40. Lietman TM, Gaynor B, Porco T. Single-dose azithromycin for trachoma. N Engl J Med. 2005 Jan 27; 352(4):414-5; author reply 414-5.
        View in: PubMed
      41. Chidambaram JD, Bird M, Schiedler V, Fry AM, Porco T, Bhatta RC, Jha H, Chaudary JS, Gaynor B, Yi E, Whitcher JP, Osaki-Holm S, Lietman TM. Trachoma decline and widespread use of antimicrobial drugs. Emerg Infect Dis. 2004 Nov; 10(11):1895-9.
        View in: PubMed
      42. Chidambaram JD, Melese M, Alemayehu W, Yi E, Prabriputaloong T, Lee DC, Cevallos V, Zhou Z, Whitcher JP, Gaynor BD, Lietman TM. Mass antibiotic treatment and community protection in trachoma control programs. Clin Infect Dis. 2004 Nov 1; 39(9):e95-7.
        View in: PubMed
      43. Melese M, Chidambaram JD, Alemayehu W, Lee DC, Yi EH, Cevallos V, Zhou Z, Donnellan C, Saidel M, Whitcher JP, Gaynor BD, Lietman TM. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA. 2004 Aug 11; 292(6):721-5.
        View in: PubMed
      44. Miller K, Schmidt G, Melese M, Alemayehu W, Yi E, Cevallos V, Donnellan C, Olinger L, Fantaye D, Gaynor B, Whitcher JP, Lietman T. How reliable is the clinical exam in detecting ocular chlamydial infection? Ophthalmic Epidemiol. 2004 Jul; 11(3):255-62.
        View in: PubMed
      45. Miller K, Pakpour N, Yi E, Melese M, Alemayehu W, Bird M, Schmidt G, Cevallos V, Olinger L, Chidambaram J, Gaynor B, Whitcher J, Lietman T. Pesky trachoma suspect finally caught. Br J Ophthalmol. 2004 Jun; 88(6):750-1.
        View in: PubMed
      46. Melese M, Alemayehu W, Gaynor B, Yi E, Whitcher JP, Lietman TM. What more is there to learn about trachoma? Br J Ophthalmol. 2003 May; 87(5):521-2.
        View in: PubMed
      47. Gaynor BD, Miao Y, Cevallos V, Jha H, Chaudary JS, Bhatta R, Osaki-Holm S, Yi E, Schachter J, Whitcher JP, Lietman T. Eliminating trachoma in areas with limited disease. Emerg Infect Dis. 2003 May; 9(5):596-8.
        View in: PubMed
      48. Gaynor BD, Holbrook KA, Whitcher JP, Holm SO, Jha HC, Chaudhary JS, Bhatta RC, Lietman T. Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year. Br J Ophthalmol. 2003 Feb; 87(2):147-8.
        View in: PubMed
      49. Jha H, Chaudary JS, Bhatta R, Miao Y, Osaki-Holm S, Gaynor B, Zegans M, Bird M, Yi E, Holbrook K, Whitcher JP, Lietman T. Disappearance of trachoma from Western Nepal. Clin Infect Dis. 2002 Sep 15; 35(6):765-8.
        View in: PubMed
      50. Fry AM, Jha HC, Lietman TM, Chaudhary JS, Bhatta RC, Elliott J, Hyde T, Schuchat A, Gaynor B, Dowell SF. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clin Infect Dis. 2002 Aug 15; 35(4):395-402.
        View in: PubMed
      51. Gaynor BD, Yi E, Lietman T. Rationale for mass antibiotic distribution for trachoma elimination. Int Ophthalmol Clin. 2002; 42(1):85-92.
        View in: PubMed
      52. Gaynor BD, Wade NK, Cunningham ET. Herpes simplex virus type 1 associated acute retinal necrosis following encephalitis. Retina. 2001; 21(6):688-90.
        View in: PubMed
      53. Gaynor BD, Stamper RL, Cunningham ET. Presumed activation of herpetic keratouveitis after Argon laser peripheral iridotomy. Am J Ophthalmol. 2000 Nov; 130(5):665-7.
        View in: PubMed
      54. Gaynor BD, Margolis TP, Cunningham ET. Advances in diagnosis and management of herpetic uveitis. Int Ophthalmol Clin. 2000; 40(2):85-109.
        View in: PubMed
      Bruce's Networks
      Click the "See All" links for more information and interactive visualizations!
      Related Concepts
      Derived automatically from this person's publications.
      See all (170) concept(s)
      _
      Co-Authors
      People in Profiles who have published with this person.
      See all (11) people
      _
      Related Authors
      People who share similar concepts with this person.
      See all (60) people
      _
      Same Department
      Search Department
      Back to TOP